← Back to Clinical Trials
Recruiting NCT06660550

NCT06660550 Needlescopic Versus Traditional Laparoscopic Inguinal Hernia Repair in Pediatrics

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06660550
Status Recruiting
Phase
Sponsor Sohag University
Condition Congenital Inguinal Hernia
Study Type INTERVENTIONAL
Enrollment 20 participants
Start Date 2024-11-01
Primary Completion 2025-05

Eligibility & Interventions

Sex All sexes
Min Age N/A
Max Age 18 Years
Study Type INTERVENTIONAL
Interventions
laparoscopic inguinal hernia repairNeedlescopic inguinal hernia repair

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 20 participants in total. It began in 2024-11-01 with a primary completion date of 2025-05.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The aim of the study is to evaluate the results of Needlescopic inguinal hernia repair in comparison with traditional laparoscopic repair in children as regard operative time, cosmetic appearance, recurrence and other complications.

Eligibility Criteria

Inclusion Criteria: * Include patients presented with inguinal hernia with age \< 18 years. Exclusion Criteria: 1. Age above 18 years. 2. Complicated inguinal hernia (e.g. irreducibility, obstruction and strangulation). 3. Pervious lower abdominal surgeries.

Contact & Investigator

Central Contact

Abdelaziz A Abdelaziz, Resident

✉ abdelazeez.ali@med.sohag.edu.eg

📞 00201010274505

Frequently Asked Questions

Who can join the NCT06660550 clinical trial?

This trial is open to participants of all sexes, up to 18 Years, studying Congenital Inguinal Hernia. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06660550 currently recruiting?

Yes, NCT06660550 is actively recruiting participants. Contact the research team at abdelazeez.ali@med.sohag.edu.eg for enrollment information.

Where is the NCT06660550 trial being conducted?

This trial is being conducted at Sohag, Egypt.

Who is sponsoring the NCT06660550 clinical trial?

NCT06660550 is sponsored by Sohag University. The trial plans to enroll 20 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: July 2026  ·  Data Methodology